AAAAAA

   
Results: 1-18 |
Results: 18

Authors: Bergeron, Y Gauthier, S Kafka, V Lefort, P Lesieur, D
Citation: Y. Bergeron et al., Natural fire frequency for the eastern Canadian boreal forest: consequences for sustainable forestry, CAN J FORES, 31(3), 2001, pp. 384-391

Authors: Chavatte, P Yous, S Lesieur, D Henichart, JP
Citation: P. Chavatte et al., Conformational analysis of tripeptide Ac-Lys-Pro-Val-NH2, COOH-terminal sequence of alpha-MSH, J PHARM PHA, 53(7), 2001, pp. 949-953

Authors: Chavatte, P Yous, S Marot, C Baurin, N Lesieur, D
Citation: P. Chavatte et al., Three-dimensional quantitative structure-activity relationships of cyclo-oxygenase-2 (COX-2) inhibitors: A comparative molecular field analysis, J MED CHEM, 44(20), 2001, pp. 3223-3230

Authors: Delhomel, JF Yous, S Depreux, P Lesieur, D
Citation: Jf. Delhomel et al., Synthesis of 2(3H)-benzoxazolone and 2(3H)-benzothiazolone derivatives as potential beta-3-adrenergic receptor ligands (part 2), J HETERO CH, 38(3), 2001, pp. 633-639

Authors: Marot, C Chavatte, P Lesieur, D
Citation: C. Marot et al., Comparative molecular field analysis of selective cyclooxygenase-2 (COX-2)inhibitors, QSAR, 19(2), 2000, pp. 127-134

Authors: Merle, A Delagrange, P Renard, P Lesieur, D Cuber, JC Roche, M Pellissier, S
Citation: A. Merle et al., Effect of melatonin on motility pattern of small intestine in rats and itsinhibition by melatonin receptor antagonist S 22153, J PINEAL R, 29(2), 2000, pp. 116-124

Authors: Varlet, D Fourmaintraux, E Depreux, P Lesieur, D
Citation: D. Varlet et al., Synthesis of 4-[4 '-(N-N-dimethylsulfamoyl)piperazin-1-yl]-pyridine derivatives as sorbitol dehydrogenase potential inhibitors, HETEROCYCLE, 53(4), 2000, pp. 797-804

Authors: Ferry, G Loynel, A Kucharczyk, N Bertin, S Rodriguez, M Delagrange, P Galizzi, JP Jacoby, E Volland, JP Lesieur, D Renard, P Canet, E Fauchere, JL Boutin, JA
Citation: G. Ferry et al., Substrate specificity and inhibition studies of human serotonin N-acetyltransferase (vol 275, pg 8794, 2000), J BIOL CHEM, 275(50), 2000, pp. 39799-39799

Authors: Ferry, G Loynel, AM Kucharczyk, N Bertin, S Rodriguez, M Delagrange, P Galizzi, JP Jacoby, E Volland, JP Lesieur, D Renard, P Canet, E Fauchere, JL Boutin, JA
Citation: G. Ferry et al., Substrate specificity and inhibition studies of human serotonin N-acetyltransferase, J BIOL CHEM, 275(12), 2000, pp. 8794-8805

Authors: Conway, S Canning, SJ Howell, HE Mowat, ES Barrett, P Drew, JE Delagrange, P Lesieur, D Morgan, PJ
Citation: S. Conway et al., Characterisation of human melatonin mt(1) and MT2 receptors by CRE-luciferase reporter assay, EUR J PHARM, 390(1-2), 2000, pp. 15-24

Authors: Kopp, C Vogel, E Rettori, MC Delagrange, P Renard, P Lesieur, D Misslin, R
Citation: C. Kopp et al., Regulation of emotional behaviour by day length in mice: implication of melatonin, BEHAV PHARM, 10(8), 1999, pp. 747-752

Authors: Gozzo, A Lesieur, D Duriez, P Fruchart, JC Teissier, E
Citation: A. Gozzo et al., Structure-activity relationships in a series of melatonin analogues with the low-density lipoprotein oxidation model, FREE RAD B, 26(11-12), 1999, pp. 1538-1543

Authors: Liacha, M Yous, S Depreux, P Poupaert, JH Lesieur, D
Citation: M. Liacha et al., Synthesis of N-(4,6-dimethylpyridin-2-yl)-benzoxazolinonyl methylcarboxamides with potential antiinflammatory activity, HETEROCYCLE, 51(8), 1999, pp. 1929-1943

Authors: Kopp, C Vogel, E Rettori, MC Delagrange, P Renard, P Lesieur, D Misslin, R
Citation: C. Kopp et al., Antagonistic effects of S 22153, a new mt1 and MT2 receptor ligand, on theneophobia-reducing properties of melatonin in BALB/c mice, PHARM BIO B, 64(1), 1999, pp. 131-136

Authors: Delhomel, JF Yous, S Depreux, P Lesieur, D
Citation: Jf. Delhomel et al., Synthesis of 2(3H)-benzoxazolinone derivatives as potential beta-3-adrenergic receptor ligands, J HETERO CH, 36(5), 1999, pp. 1241-1245

Authors: Weibel, L Rettori, MC Lesieur, D Delagrange, P Renard, P Van Reeth, O
Citation: L. Weibel et al., A single oral dose of S 22153, a melatonin antagonist, blocks the phase advancing effects of melatonin in C3H mice, BRAIN RES, 829(1-2), 1999, pp. 160-166

Authors: Lesieur, D Leclerc, V Chavatte, P Marot, C Renard, P Guardiola-Lemaitre, B
Citation: D. Lesieur et al., Melatonin, a suitable lead compound for rational drug design, THERAPIE, 53(5), 1998, pp. 429-437

Authors: Bizot-Espiard, JG Double, A Cousin, B Lesieur, D Guardiola-Lemaitre, B Delagrange, P Ktorza, A Penicaud, L
Citation: Jg. Bizot-espiard et al., Lack of melatonin effects on insulin action in normal rats, HORMONE MET, 30(12), 1998, pp. 711-716
Risultati: 1-18 |